Report cover image

Global Valsartan Capsules Market Analysis and Forecast 2025-2031

Publisher APO Research, Inc.
Published Jul 08, 2025
Length 193 Pages
SKU # APRC20283340

Description

Summary

According to APO Research, The global Valsartan Capsules market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Valsartan Capsules is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Valsartan Capsules is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Valsartan Capsules is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Valsartan Capsules is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Valsartan Capsules include Conquer, Dynemed, Mylan, Lepu Medical, Cisen Pharmaceutical, Torrent Pharmaceuticals, Teva Pharmaceutical Industries, Sun Pharmaceutical and Novartis, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Valsartan Capsules, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Valsartan Capsules, also provides the sales of main regions and countries. Of the upcoming market potential for Valsartan Capsules, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Valsartan Capsules sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Valsartan Capsules market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Valsartan Capsules sales, projected growth trends, production technology, application and end-user industry.

Valsartan Capsules Segment by Company

Conquer
Dynemed
Mylan
Lepu Medical
Cisen Pharmaceutical
Torrent Pharmaceuticals
Teva Pharmaceutical Industries
Sun Pharmaceutical
Novartis
Valsartan Capsules Segment by Type

160 Mg
40 Mg
80 Mg
Others
Valsartan Capsules Segment by Application

Treatment of Hypertension
Treatment of Heart Disease
Others
Valsartan Capsules Segment by Region

North America
United States
Canada
Mexico
Europe

Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific

China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America

Brazil
Argentina
Chile
Middle East & Africa

Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Valsartan Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Valsartan Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Valsartan Capsules.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Valsartan Capsules in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Valsartan Capsules manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Valsartan Capsules sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

193 Pages
1 Market Overview
1.1 Product Definition
1.2 Valsartan Capsules Market by Type
1.2.1 Global Valsartan Capsules Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 160 Mg
1.2.3 40 Mg
1.2.4 80 Mg
1.2.5 Others
1.3 Valsartan Capsules Market by Application
1.3.1 Global Valsartan Capsules Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Treatment of Hypertension
1.3.3 Treatment of Heart Disease
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Valsartan Capsules Market Dynamics
2.1 Valsartan Capsules Industry Trends
2.2 Valsartan Capsules Industry Drivers
2.3 Valsartan Capsules Industry Opportunities and Challenges
2.4 Valsartan Capsules Industry Restraints
3 Global Market Growth Prospects
3.1 Global Valsartan Capsules Revenue Estimates and Forecasts (2020-2031)
3.2 Global Valsartan Capsules Revenue by Region
3.2.1 Global Valsartan Capsules Revenue by Region: 2020 VS 2024 VS 2031
3.2.2 Global Valsartan Capsules Revenue by Region (2020-2025)
3.2.3 Global Valsartan Capsules Revenue by Region (2026-2031)
3.2.4 Global Valsartan Capsules Revenue Market Share by Region (2020-2031)
3.3 Global Valsartan Capsules Sales Estimates and Forecasts 2020-2031
3.4 Global Valsartan Capsules Sales by Region
3.4.1 Global Valsartan Capsules Sales by Region: 2020 VS 2024 VS 2031
3.4.2 Global Valsartan Capsules Sales by Region (2020-2025)
3.4.3 Global Valsartan Capsules Sales by Region (2026-2031)
3.4.4 Global Valsartan Capsules Sales Market Share by Region (2020-2031)
3.5 US & Canada & Mexico
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
4.1 Global Valsartan Capsules Revenue by Manufacturers
4.1.1 Global Valsartan Capsules Revenue by Manufacturers (2020-2025)
4.1.2 Global Valsartan Capsules Revenue Market Share by Manufacturers (2020-2025)
4.1.3 Global Valsartan Capsules Manufacturers Revenue Share Top 10 and Top 5 in 2024
4.2 Global Valsartan Capsules Sales by Manufacturers
4.2.1 Global Valsartan Capsules Sales by Manufacturers (2020-2025)
4.2.2 Global Valsartan Capsules Sales Market Share by Manufacturers (2020-2025)
4.2.3 Global Valsartan Capsules Manufacturers Sales Share Top 10 and Top 5 in 2024
4.3 Global Valsartan Capsules Sales Price by Manufacturers (2020-2025)
4.4 Global Valsartan Capsules Key Manufacturers Ranking, 2023 VS 2024 VS 2025
4.5 Global Valsartan Capsules Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Valsartan Capsules Manufacturers, Product Type & Application
4.7 Global Valsartan Capsules Manufacturers' Establishment Date
4.8 Market Competitive Analysis
4.8.1 Global Valsartan Capsules Market CR5 and HHI
4.8.2 2024 Valsartan Capsules Tier 1, Tier 2, and Tier 3
5 Valsartan Capsules Market by Type
5.1 Global Valsartan Capsules Revenue by Type
5.1.1 Global Valsartan Capsules Revenue by Type (2020 VS 2024 VS 2031)
5.1.2 Global Valsartan Capsules Revenue by Type (2020-2031) & (US$ Million)
5.1.3 Global Valsartan Capsules Revenue Market Share by Type (2020-2031)
5.2 Global Valsartan Capsules Sales by Type
5.2.1 Global Valsartan Capsules Sales by Type (2020 VS 2024 VS 2031)
5.2.2 Global Valsartan Capsules Sales by Type (2020-2031) & (K Units)
5.2.3 Global Valsartan Capsules Sales Market Share by Type (2020-2031)
5.3 Global Valsartan Capsules Price by Type
6 Valsartan Capsules Market by Application
6.1 Global Valsartan Capsules Revenue by Application
6.1.1 Global Valsartan Capsules Revenue by Application (2020 VS 2024 VS 2031)
6.1.2 Global Valsartan Capsules Revenue by Application (2020-2031) & (US$ Million)
6.1.3 Global Valsartan Capsules Revenue Market Share by Application (2020-2031)
6.2 Global Valsartan Capsules Sales by Application
6.2.1 Global Valsartan Capsules Sales by Application (2020 VS 2024 VS 2031)
6.2.2 Global Valsartan Capsules Sales by Application (2020-2031) & (K Units)
6.2.3 Global Valsartan Capsules Sales Market Share by Application (2020-2031)
6.3 Global Valsartan Capsules Price by Application
7 Company Profiles
7.1 Conquer
7.1.1 Conquer Comapny Information
7.1.2 Conquer Business Overview
7.1.3 Conquer Valsartan Capsules Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Conquer Valsartan Capsules Product Portfolio
7.1.5 Conquer Recent Developments
7.2 Dynemed
7.2.1 Dynemed Comapny Information
7.2.2 Dynemed Business Overview
7.2.3 Dynemed Valsartan Capsules Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Dynemed Valsartan Capsules Product Portfolio
7.2.5 Dynemed Recent Developments
7.3 Mylan
7.3.1 Mylan Comapny Information
7.3.2 Mylan Business Overview
7.3.3 Mylan Valsartan Capsules Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Mylan Valsartan Capsules Product Portfolio
7.3.5 Mylan Recent Developments
7.4 Lepu Medical
7.4.1 Lepu Medical Comapny Information
7.4.2 Lepu Medical Business Overview
7.4.3 Lepu Medical Valsartan Capsules Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Lepu Medical Valsartan Capsules Product Portfolio
7.4.5 Lepu Medical Recent Developments
7.5 Cisen Pharmaceutical
7.5.1 Cisen Pharmaceutical Comapny Information
7.5.2 Cisen Pharmaceutical Business Overview
7.5.3 Cisen Pharmaceutical Valsartan Capsules Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Cisen Pharmaceutical Valsartan Capsules Product Portfolio
7.5.5 Cisen Pharmaceutical Recent Developments
7.6 Torrent Pharmaceuticals
7.6.1 Torrent Pharmaceuticals Comapny Information
7.6.2 Torrent Pharmaceuticals Business Overview
7.6.3 Torrent Pharmaceuticals Valsartan Capsules Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Torrent Pharmaceuticals Valsartan Capsules Product Portfolio
7.6.5 Torrent Pharmaceuticals Recent Developments
7.7 Teva Pharmaceutical Industries
7.7.1 Teva Pharmaceutical Industries Comapny Information
7.7.2 Teva Pharmaceutical Industries Business Overview
7.7.3 Teva Pharmaceutical Industries Valsartan Capsules Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Teva Pharmaceutical Industries Valsartan Capsules Product Portfolio
7.7.5 Teva Pharmaceutical Industries Recent Developments
7.8 Sun Pharmaceutical
7.8.1 Sun Pharmaceutical Comapny Information
7.8.2 Sun Pharmaceutical Business Overview
7.8.3 Sun Pharmaceutical Valsartan Capsules Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Sun Pharmaceutical Valsartan Capsules Product Portfolio
7.8.5 Sun Pharmaceutical Recent Developments
7.9 Novartis
7.9.1 Novartis Comapny Information
7.9.2 Novartis Business Overview
7.9.3 Novartis Valsartan Capsules Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Novartis Valsartan Capsules Product Portfolio
7.9.5 Novartis Recent Developments
8 North America
8.1 North America Valsartan Capsules Market Size by Type
8.1.1 North America Valsartan Capsules Revenue by Type (2020-2031)
8.1.2 North America Valsartan Capsules Sales by Type (2020-2031)
8.1.3 North America Valsartan Capsules Price by Type (2020-2031)
8.2 North America Valsartan Capsules Market Size by Application
8.2.1 North America Valsartan Capsules Revenue by Application (2020-2031)
8.2.2 North America Valsartan Capsules Sales by Application (2020-2031)
8.2.3 North America Valsartan Capsules Price by Application (2020-2031)
8.3 North America Valsartan Capsules Market Size by Country
8.3.1 North America Valsartan Capsules Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
8.3.2 North America Valsartan Capsules Sales by Country (2020 VS 2024 VS 2031)
8.3.3 North America Valsartan Capsules Price by Country (2020-2031)
8.3.4 United States
8.3.5 Canada
8.3.6 Mexico
9 Europe
9.1 Europe Valsartan Capsules Market Size by Type
9.1.1 Europe Valsartan Capsules Revenue by Type (2020-2031)
9.1.2 Europe Valsartan Capsules Sales by Type (2020-2031)
9.1.3 Europe Valsartan Capsules Price by Type (2020-2031)
9.2 Europe Valsartan Capsules Market Size by Application
9.2.1 Europe Valsartan Capsules Revenue by Application (2020-2031)
9.2.2 Europe Valsartan Capsules Sales by Application (2020-2031)
9.2.3 Europe Valsartan Capsules Price by Application (2020-2031)
9.3 Europe Valsartan Capsules Market Size by Country
9.3.1 Europe Valsartan Capsules Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
9.3.2 Europe Valsartan Capsules Sales by Country (2020 VS 2024 VS 2031)
9.3.3 Europe Valsartan Capsules Price by Country (2020-2031)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
9.3.9 Spain
9.3.10 Netherlands
10 China
10.1 China Valsartan Capsules Market Size by Type
10.1.1 China Valsartan Capsules Revenue by Type (2020-2031)
10.1.2 China Valsartan Capsules Sales by Type (2020-2031)
10.1.3 China Valsartan Capsules Price by Type (2020-2031)
10.2 China Valsartan Capsules Market Size by Application
10.2.1 China Valsartan Capsules Revenue by Application (2020-2031)
10.2.2 China Valsartan Capsules Sales by Application (2020-2031)
10.2.3 China Valsartan Capsules Price by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Valsartan Capsules Market Size by Type
11.1.1 Asia Valsartan Capsules Revenue by Type (2020-2031)
11.1.2 Asia Valsartan Capsules Sales by Type (2020-2031)
11.1.3 Asia Valsartan Capsules Price by Type (2020-2031)
11.2 Asia Valsartan Capsules Market Size by Application
11.2.1 Asia Valsartan Capsules Revenue by Application (2020-2031)
11.2.2 Asia Valsartan Capsules Sales by Application (2020-2031)
11.2.3 Asia Valsartan Capsules Price by Application (2020-2031)
11.3 Asia Valsartan Capsules Market Size by Country
11.3.1 Asia Valsartan Capsules Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
11.3.2 Asia Valsartan Capsules Sales by Country (2020 VS 2024 VS 2031)
11.3.3 Asia Valsartan Capsules Price by Country (2020-2031)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 Taiwan
11.3.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Valsartan Capsules Market Size by Type
12.1.1 SAMEA Valsartan Capsules Revenue by Type (2020-2031)
12.1.2 SAMEA Valsartan Capsules Sales by Type (2020-2031)
12.1.3 SAMEA Valsartan Capsules Price by Type (2020-2031)
12.2 SAMEA Valsartan Capsules Market Size by Application
12.2.1 SAMEA Valsartan Capsules Revenue by Application (2020-2031)
12.2.2 SAMEA Valsartan Capsules Sales by Application (2020-2031)
12.2.3 SAMEA Valsartan Capsules Price by Application (2020-2031)
12.3 SAMEA Valsartan Capsules Market Size by Country
12.3.1 SAMEA Valsartan Capsules Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
12.3.2 SAMEA Valsartan Capsules Sales by Country (2020 VS 2024 VS 2031)
12.3.3 SAMEA Valsartan Capsules Price by Country (2020-2031)
12.3.4 Brazil
12.3.5 Argentina
12.3.6 Chile
12.3.7 Colombia
12.3.8 Peru
12.3.9 Saudi Arabia
12.3.10 Israel
12.3.11 UAE
12.3.12 Turkey
12.3.13 Iran
12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
13.1 Valsartan Capsules Value Chain Analysis
13.1.1 Valsartan Capsules Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Valsartan Capsules Production Mode & Process
13.2 Valsartan Capsules Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Valsartan Capsules Distributors
13.2.3 Valsartan Capsules Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.